Can we gain insight to the genetic etiology of diseases using a limited number of genomes (few hundred)? Can small data sets lend insights that large data sets may subsequently confirm? Here, I show how common genetic variants, which were identified only from hundreds of individuals, may be used to gain unique insights regarding the disease etiology of a common lifestyle-related disease.
Introduction
The human evolution [4] [5] [6] [7] is a continuous process of adaptation [9, 10] during which we have developed immunity against diseases in general [11] , as well as local to a region [12] , and also kept pace with the dietary changes [14] , external conditions of habitat [15] [16] [17] , and geography [20] . In a comparative genomic study, we may invoke conserved (or invariant) genetic information to trace the shared ancestry [21, 22] . Inspired by a recent report that a healthy lifestyle may reverse some adverse consequences related to cardiovascular disease (CVD) [23] , and merging comparative genomics with evolutionary biology, we present insights and new perspectives to rationalize the disease etiology. Moreover, it has been long been suggested that an evolutionary standpoint may improve our understanding of common lifestyle-related diseases such as CVD [24, 25] , and recent reports suggest the limitations of converging toward a consensus set of causative variants from diverse studies [26] [27] [28] [29] .
Cardiovascular disease has been attributed to a plethora of genetic variants, which involve lipid regulation [30] [31] [32] [33] , inflammation [34] [35] [36] , as well as other epigenetic agents such as an altered lifestyle [38, 39] . Genome wide association studies involving thousands of individuals, have identified hundreds of causative and associated variants to understand the genetic etiology of CVD [40] [41] [42] [43] , but it has been estimated that the spectrum of identified variants does not fully represent the inherited risk [29, [40] [41] [42] [43] [44] . The genetic etiology of such lifestyle-related diseases can seldom be identical in an outbred population because their ancestries may differ [45] . Hence, not all variants may be identified with high statistical confidence from a specific genome wide association study (GWAS), as suggested schematically in Fig. 1 (adapted from [46] ). Therefore, most importantly, results of GWA studies, from distinct subpopulations may differ because the 4 causative variants may not be identified with similar statistical confidence and the ancestry of individuals with CVD may also differ [44] .
Besides a well-documented set of candidate genes associated with cardiac diseases [47] , there are other genes that may differentially affect their prognosis, for example DNA damage repair (DDR) genes TP53 and MDM2 have been recently implicated in cardiomyocyte function [48] . In this report, we propose that an evolutionary study may be invoked to trace a genetic etiology of CVD in an outbred subpopulation, and overcome the challenges of a small data set. From our proposed formulation, we may be able to corroborate previously implicated CVD genes (and their variants) and also identify new ones. As onset of CVD is largely lifestyle-related in the general population [23] , we hypothesize that the disease etiology may be traced by contrasting distinct variants of the same gene. In fact it is well established that specific mutations (generally referred to as variants) of the receptor LDL receptor gene (LDLR) cause hypercholesterolemia, and might lead to high risk of myocardial infarction [49] , but other mutations of LDLR may in fact be protective against increased LDL levels [49] .
Using microarray technology, an invariant genotype can be detected from the genomewide genotype that was probed across various individuals in an outbred subpopulation, at a specifically predetermined single nucleotide polymorphic (SNP) locus. In a comparative genomic study across those subjects, the genotype for a hypothetical common ancestor for the specific cohort may thus be unambiguously determined at that SNP locus. Their hypothetical last common ancestral genome of that outbred subpopulation will also manifest the same invariant genotype at the SNP locus, which has remained invariant subsequent to evolution [50] . Hence, we hypothesize that such SNP loci with invariant genotype (common alleles from that subpopulation), which have resisted mutations, may be utilized to trace the genetic etiology of CVD cases with respect to age-and gender-matched controls. The occurrence of common genetic variants at any given genomic locus is an inevitable consequence of evolution within an outbred population [51] , because those variants may progressively get inherited over generations [52] . Such common variants are likely to be a relatively recent outcome of evolution compared to invariant ones, but presumably older than the relatively rare variants [52] . However, there is a caveat that rare variations are either likely to be new (few generations old) and hence they have not been subject to negative selection for a long time, or are rare because they are being selected against owing to their deleterious genetic nature and are likely have greater penetrance in contrast to that due to common variants [52] [53] [54] .
By partitioning human noncoding sequence into invariant (conserved) and variant (nonconserved) loci, it has been reported that agents of natural selection have influenced the human genome evolution [55] . Hence, from the perspective of a comparative genomic approach, interactions involving both invariant and variant genomic loci may lead to gain-of-function (adaptation) or loss-of-function [56, 57] or perhaps remain benign without any perceptible change at the genome-level [58, 59] . However, the adverse consequences of these changes may manifest later on during mid-life, much beyond the average reproductive age at the population level. For example, it has been suggested that high levels of cytokine response may confer an innate resistance to infectious diseases at an early age, and that the same response inadvertently becomes adversely associated with CVD at a much later age [60] . An evolutionary adaptation that confers reproducibility success at a relatively early age, but which may adversely affects us later, has also been reported with regard to an ancient variant allele at the growth differentiation factor-5 (GDF5) enhancer region [20] . Taken together, the constellation of 6 genetic variants may have a profound impact at the individual genome level [61] [62] [63] .
Therefore, by reaching an appreciable frequency in a subpopulation, common variants (evolutionary adaptations) are instrumental for a differential physiological response such that the level of severity may be stratified. Therefore, we propose that the genetic etiology for CVD may be investigated in an outbred subpopulation of patients and agematched healthy controls using common variants identified from patients with stratified severity level of this disease. We hypothesize that a hierarchical nature of those common genetic variants among patients with disparate severity may help trace the evolution of CVD severity.
Traditional GWA studies for complex multifactorial diseases warrant genome-wide data from thousands of individuals to identify causative variants with high statistical confidence [46] . Therefore, it has been a challenge to characterize the genetic etiology of CVD from India with access to genotype information from nearly one hundred and fifty CVD cases, and an identical number of age-and gender-matched controls. To overcome the limitation of a small data size, we propose insights and perspectives for an inter-disciplinary approach, and hierarchically trace genome-wide common genetic variants among CVD cases with stratified levels of severity that was determined from angiography-based studies [64, 65] .
At first, we must present a primer on protein sequence evolution to elucidate its potential using published reports. This synopsis relates to proteins in general, and DNA damage repair proteins in particular, but the insights developed here are for a relatively wider and general application to genomes. Therefore, the insights and perspectives here are addressed to the larger community, inclusive of clinicians and non-clinicians.
Genome sequence evolution using computer-based comparative genomics approaches
The DNA damage repair genes All eukaryotic living cells experience DNA breaks in their nucleus due to a plethora of endogenous and exogenous agents, and have evolved intrinsic molecular mechanisms to repair those lesions [66] . If left unrepaired, the physiological consequences may be lethal for the cell [67] . Such mechanisms for repair constitute a network of bio-chemical pathways called DNA damage response (DDR) pathways [68] , the regulation of which is largely evolutionarily conserved [69]. For example, in the instance of metabolic syndrome, it has been suggested that system-level DDR may impinge on energy metabolism and vascular physiology [68] . Moreover, when the genes that encode human DDR proteins undergo mutations, the inherent genome-wide repair mechanism may breakdown, which may lead to ischemic stress [70] , CVD [71, 72] , or certain cancers [73] [74] [75] . Over a hundred different genes encoding the various human DDR proteins [76, 77] , and belonging to disparate DDR pathways [66, 78] , are publicly available at: http://sciencepark.mdanderson.org/labs/wood/dna_repair_ genes.html .
Evolutionarily related proteins (or the genes encoding them) are referred to as homologs. The homologs within the same organism, which are a consequence of gene sequences that coalesce [79] at specific within-genome replication event (such as a gene duplication event) are termed paralogs. On the other hand, when gene sequences coalesce [79] at a speciation event they give rise to orthologs. The mathematical formulations of this coalescent theory have been extensively implemented (for example [80] ) and covered extensively (for example [81] ). Genes encoding orthologs and paralogs have largely evolved by gene duplication events, as well as other evolutionary processes such as retroposition, intron-mediated recombination (exon shuffling and trans-splicing), horizontal gene transfer and de novo organization (reviewed in [82] ). For this comparative genomics approach, an accurate multiple sequence alignment (MSA) is critical for drawing an accurate inference [83] . The MSA is primarily a mathematically derived arrangement of nucleotide or amino acid (AA) sequence (or may merely represent domains / motifs / fragments of the full sequence), of three or more homologs representing their overall ancestry.
Homologous proteins have evolved among diverse species, and the ones that are critical for multiple functions, may largely remain conserved at the amino acid residue (AA) level, and under strong negative selection [84] [85] [86] [87] . As most DDR proteins are ubiquitous and play a relatively central role in cellular processes within an organism, it is plausible that they are largely under strong selection pressure and evolutionarily conserved [18, 86] . However, random mutations can give rise to variants at the codon-level, which in may turn out advantageous and may get incorporated or "fixed" in a population, or subpopulation, by natural selection [88] . From among all possible mutations, the ones that are advantageous to the organism's fitness, and enable it to adapt and thrive in its habitat will be discussed later. These genomic adaptations are not exclusively single nucleotide variants (SNVs), and include instances when molecular adaptions in host organisms were geared to avert insertion of mobile elements, such as transposons, from parasite genomes [89, 90] . However, before a rare mutation gets "fixed" in the population, they first manifest as polymorphisms in subpopulations, and can have interesting physiological consequences [91] . To showcase the importance of genetic invariants and common variants during genome evolution, we synopsize some select reports of molecular adaptations of among various DDR genes, across different species. 9 To predict the AAs that are important for the protein structure and/or function, computational methods are used to delineate evolutionarily conserved AA positions in a MSA (columns of AAs). DNA repair proteins from E. coli and S. cerevisiae have been compared to protein sequences encoded in completely sequenced genomes of disparate bacteria, archaea and eukaryotes [92] . In that study, the authors identified conserved domains in DDR proteins across kingdoms and highlighted that horizontal gene transfer and epigenetic regulation influenced their sequence composition [92] .
Subsequently, independent studies have identified homologous DDR proteins in disparate species, such as E. coli, S. cervevisiae, M. musculus and H. sapiens [69, 93, 94] . Moreover, it is noteworthy that analogous roles of orthologous proteins (such as RecA/RAD51) have been traced across eukaryotes: in bacteria, yeast and mammals [69, 94] . As another example, nearly two decades ago, two independent comparative sequence analysis of yeast DDR protein with its orthologs, and E. coli DDR protein with its orthologs have led to discoveries of novel orthologous human DDR proteins [95, 96 ].
An important component of comparative sequence analysis is the in silico modeling of the AA sequence evolution. Codon-based models of gene evolution, such as Phylogenetic Analysis by Maximum Likelihood (PAML) [2] and Selecton [13] (see Box 1), use MSAs of closely related nucleotide sequences to compute the evolutionary selection pressure at the codon-level, and differentiate positive selection with respect to negative selection and neutral evolution. 
Box 1
Special codon-based models of gene evolution, such as modules/suites available from PAML [2] and Selecton [13] , have been developed to simulate single nucleotide substitutions among orthologs and paralogs. Among the various modules implemented, the one most relevant to our report is the one that simulates SNVs to compute the evolutionary selection pressure at the codon-level for a given MSA of homologs. "Silent" mutations, which are synonymous nucleotide substitutions do not change the translated AA sequence so their substitution rate d s (also called Ks) is not subject to a selection pressure on the expressed protein [18, 19] . Such mutations are more prevalent in an organism compared to the nonsynonymous ones. The nonsynonymous substitutions alter the amino acid sequence and their substitution rate d N (also called K A ) is a function of the selective pressure on the protein [18, 19] .
A measure of the selection pressure at the codon level is subsequently obtained from their ratio ௗ ಿ ௗ ೄ (also called ಲ ೄ ), also referred to as ߱ [18, 19] . To ensure an unbiased estimate of this ratio, an average of one nonsynonymous substitution may be faithfully represented at the codon level (numerator ݀ ே ~ 1 
Box 2

P53 as a representative example for comparative study across species
The human tumor suppressor gene (TP53) (an oncogene) encodes for the tumor suppressor protein 53, referred to as P53. To showcase its multiple roles in fundamental cellular functions, it is referred to as the "Guardian of the Genome" by David Lane [4] , and as the "Cellular Gatekeeper" by Arnold J. Levine [21] . This protein and its homologs have been extensively studied in regard to critical cellular processes such as cell cycle and DDR pathway [25] . Therefore, we synopsized molecular adaptations of P53 homologs and a select subset of its interacting proteins (subsequently referred to as a p53 sub-interactome).
A primer on p53 structural domains
A schematic of the various P53 functional domains is represented as a 1D cartoon in Fig. 2 (Adapted from [9] ). The N-terminal contains a short intrinsically disordered region, following that is the transactivation domain (TAD), which is further divided into two subdomains (TAD1 and TAD2) that bind to negative regulators, transcriptional coactivators and components of transcriptional machinery [48] [49] [50] [51] . Subsequent to that is a Proline-rich region (PRR) that favors a polyproline II helix structure and serves as a rigid linker to project the TAD distal to the DNA binding domain (DBD) [52] . In contrast to the TAD, DBD is more conserved across disparate vertebrates. Following the DBD is the C-terminal domain (CTD), comprising the tetramerization domain (TET) and the extreme C-terminus (CT).
Using a candidate gene approach, we considered two molecular interactors of p53:
MDM2 and MDMX (aliased MDM4), the genes of which have also been reported as oncogenes, being expressed in some types of cancers [97] . Murine p53 protein interacts with Mdm2 (murine ortholog of MDM2) via its N-terminal as well as core domain [98] .
Moreover, it is reported that Mdm2 binds directly to the p53 TAD1 domain to inhibit p53
interactions with its transcriptional coactivators [99] and that their binding is differentially decreased when the murine p53 CTD is deleted, mutated or even acetylated [100] . In addition, the MDMX protein is an important negative regulator of p53 in normal cells.
Bista et al. [101] have shown that the full-length MDMX contains a sequence of regulatory element (the "WWW element") that binds to its own N-terminal domain and therefore blocks the binding of MDMX to p53, and Su et al. have shown that there exists a motif 'FXXLW' motif, which is the MDM2 functional motif, in the disordered region of ….continued.
The p53 sub-interactome
Coordinated AA interactions are imperative for protein function such as folding, unfolding, and binding to other identical or non-identical proteins to form complexes.
For example, it has been demonstrated that the stability of the p53 tetramer is enhanced due to specific AA interactions of the p53 DBD with the p53 N-terminal [8] .
The AA critical for such essential function may manifest as an invariant AA across various orthologs from disparate species and resist mutations. Such a conserved position (or column) usually stands out when viewed in a fragmented MSA (or fulllength MSA of the protein). 1 4 p53 [102] . Such intricate molecular adaptations of these interacting proteins are critical as an inhibition introduces a level of functional regulation making them ideal candidates for study of a p53 sub-interactome with regard to their differential levels in function and protein sequence evolution. On the other hand, the p53 C-terminal binds to RAD51 and RAD54 and additional details of specific interactions are described in Ref [103, 104] .
We now synopsize studies that have identified genetic variations as molecular adaptations among orthologs genes of p53 and its sub-interactome. 
Box 3
Synopsis of species-specific adaptations in DDR proteins
We reiterate that the mechanism to repair endogenous and exogenous DNA damages have evolved across disparate species for their survival and proliferation. To maintain a robust DNA-repair pathway, it is plausible that a large fraction of genes are conserved but only a small subset of genes may be under positive selection pressure [18, 86] .
Positive selection at two or more unique codons within the same gene and across genes may suggest improvement or modulation of a pre-existing function [105] , for example pain-related stimuli in humans [106] . Mutations that tentatively enhance the organism's fitness are referred to as molecular adaptations and the codons within the same gene, or across different genes, are set to have co-evolved (reviewed in [107] ). In this Box, we highlight some preselected reports that have used comparative genomics to identify 1 5 specific molecular adaptations among DDR proteins across species. We sought out how have the DDR genes had adapted across those diverse species that inhabited harsh and diverse environments, which were not conducive for most mammals. For example, amongst mammals, (i) bats are the only species with flight as their mode of transport, on the other hand; (ii) blind mole rats live in subterranean conditions in extremely cold and hypoxic conditions, where sunlight may not permeate.
-Bats
The bat is the only mammal with an innate ability for sustained flight, and therefore a comparative genomic approach with respect to other diverse mammals helps uncover the putative molecular adaptations in select genes. It has been reported that nearly 23%
and 5% of bat specific mitochondrial genes and nuclear encoded oxidative phosphorylation (OXPHOS) genes are under significant positive selection respectively [108] . This prompted further investigations to test the hypothesis that positive selection of the genes facilitated in metabolic and energy needs for a sustained flight [108] . Their physical act of flight is perhaps one of the most energy consuming physical activity and therefore it is was suggested that its genes involving energy metabolism and DDR may have evolved unique molecular adaptations, which are absent in all other mammals [109] . Next, to investigate the molecular sequence evolution of the various bat genomes, a comparative genomic approach was used to study genomes from two bat species: tolerance to nonsynonymous substitutions, and the rare plasticity of non-conserved positions revealed tolerance to genetic variations, suggesting putative candidates for molecular adaptations. In particular, the authors identified the K321M non-synonymous mutation as the TP53 molecular adaptation in M. davidii and P. alecto, but the L323A mutation as an exclusive adaptation in the M. davidii sequence [109] . In gene-based studies, they established that the p53 and BRCA2 orthologs of were under positive selection pressure in M. davidii and that the LIG4 ortholog was under positive selection pressure in P. alecto [109] . Therefore, it is plausible that the molecular adaptations of M. davidii and P. alecto occurred prior to the divergence from their last common ancestor, within the bat lineage, and the unique species specific adaptations (for example L323A
in TP53 from M. davidii and the adaptation in LIG4 ortholog from P. alecto) occurred subsequent to that divergence [109] . In addition, Zhang et al. also reported that the human orthologs of ATM, RAD50, KU80 and MDM2 genes are under positive selection pressure, amply suggesting that molecular adaptations within a species usually brings about a concerted genome evolution [109] . We also reiterate that a mutation that impacts fitness (positive or negative) can be fixed by drift as well as selection [29] . A caveat is in order here that independent experimental assays performed in that study, suggest that those putative variants were a result of species adaptation and that the previously mentioned theoretical studies provided insights for an initial working hypothesis [109] . Moreover, experimental assays usually measure fitness consequence in terms of survival probability, and usually not in a complete physical and genomic environment "experienced" by the ancestor. Hence, in most instances, it is generally not possible to experimentally "confirm" a molecular adaptation.
Molecular adaptations among rodent species are synopsized in modules (2) and (3) below, and contrasted with other mammals. 
-Zokor rats
Zokor rats, blind subterranean rats, root rats and bamboo rats are spalacid rodents that are collectively referred to as mole-rats. These rodents thrive under adverse geographical conditions, for example the Tibetan plateau is a natural habitat for zokor rodents [110] . Recently, two subterranean wild zokor species (highland-dwelling
Myospalax baileyi and lowland-dwelling Myospalax cansus), and one highland-dwelling aboveground species of root vole (Microtus oeconomus) were investigated to explore the molecular adaptations in the p53 and contrast them with functional adaptations related to the harsh natural habitat and environmental stress [110] .
As previously mentioned, a part of the p53 N-terminal is intrinsically disordered [98] , and its MSA with other orthologs represents a high degree of sequence non-conservation [110] . Zhao et al. first used cues from protein sequence comparison and computational biology to narrow down the search for putative molecular adaptations at the codon-level in the p53 DBD, which was subsequently cross-checked using site-specific mutagenesis assay [110] . The DBD is relatively more conserved compared to the TAD and CTD and an unambiguous MSA from DBD was first obtained across orthologs, from humans to many different rodents [110] . For the purpose of this synopsis, we highlight that the sequence conservation of domain is disrupted by a solitary non-conserved MSA position, at codon 104 in human p53 DBD. Nonsynonymous variants of p53 at codon 104 were identified in the three rodent species [110] . P53 orthologs in primates such as [110] . In addition, the authors reported that for 1 8 Myospalax baileyi, the 104N variant is responsible for the transactivation of apoptotic genes at extremely severe environmental conditions: hypoxia, hypercapnia (acidic stress, high CO 2 ) and severely low ambient temperatures [110] . Subsequently, they have also reported that the 104E nonsynonymous variant in p53 for Microtus oeconomus suppresses apoptotic gene reactivation and cell apoptosis [110] .
-Spalax rodent
Spalax a blind subterranean mole-rat belongs to the Spalacidae family. As shown in Fig.   4 , the Arginine residue is conserved across p53 sequences in humans, primates, quadrupeds and numerous rodent species [111] . Comparative sequence analysis of the p53 DBD sequence among various rodent species revealed that the Spalax, had acquired the R174K mutation [111] . However, in addition to Spalax, the R174K mutation is identified across other species such as Xenopus laevis, Monodelphis domestica, Xiphophorus maculatus, and Xiphophorus helleri (Fig. 4 , adapted from [111] ). The above nonsynonymous substitution is one of the few mutations that was adapted within the Spalax genome, and the most interesting feature is that this particular nonsynonymous substitution occurs at an otherwise well conserved position in the MSA. Additional Spalax-specific changes, with respect to human and mice, were also reported using a full-length MSA [111] . All findings motivated the authors to hypothesize that Spalax p53 gene had adapted, and enabled those rodents to thrive in an underground hypoxic environment. Subsequently, other critical adaptations related to hypoxia were also reported in Spalax [112] . (More recently, unique hypoxia-based adaptations have also been reported in the case of the naked-mole rat, another member of the same Spalacidae family [113] ). 1 9 We try to present a broader perspective here, that genome-level molecular adaptations have led to the survival and proliferation of a variety of species in harsh, stressful and disparate environments.
(End Box 3).
Next, to emphasize further that genomes have evolved uniquely across disparate species, we further synopsize some results from DDR-related pathways (see Box 4).
Box 4
Adaptations in DDR pathways
Here, using comparative genomic approaches, we highlight recent reports involving various DDR pathways, and encompassing multiple genes. We highlight recent results from the non-homologous end joining (NHEJ) repair pathway and then draw parallels invoking the homologous recombination (HR) repair pathway in bacteria and mammals.
Sequence-based computational biology analysis was used to provide insights and perspectives to predict and rationalize adaptive evolution amongst various interacting proteins. First, we synopsize two independent studies from the NHEJ pathway in this context of an adaptive molecular sequence evolution.
An evolutionary screen of proteins from the yeast genome (Saccharomyces cerevisiae and Saccharomyces paradoxus) identified various NHEJ proteins to be under adaptive evolution [89] . In that study, the authors identified a total of seventy-two positively selected genes from the yeast genome and subsequently focused on pathway-centered analysis where they identified statistically significant positive selection from NHEJ repair pathway genes and genes such as XRS2, POL4, SAE2 and NEJ1 [89] . Moreover, they 2 0 also demonstrated that the identified molecular adaptations are not a result of Saccharomyces cerevisiae adapting to laboratory conditions as they obtained similar results by using YJM789, the "wild" Saccharomyces cerevisiae isolate [89] . The rapid evolution of those proteins seemed counterintuitive because NHEJ response to DDR is a critical repair response among eukaryotes. In support of their counterintuitive results, the authors hypothesized that those NHEJ genes were under positive selection to counter the integration of Ty LTR-retrotransposons in their genome [89] . In a nutshell, that study primarily identified NHEJ genes manifesting molecular adaptations, in yeast, which were essential for its survival [89] .
In an independent comparative genomic study of proteins from the human NHEJ pathway, the authors have delineated human DDR genes under positive selective pressure [114] . Next, a separate study of human genes from Fanconi anemia BRCA (FA/BRCA) pathway is synopsized [115] . That theoretical study investigated a select set of genes:
ATM, BRCA1, BRCA2, CHK2, NBS1, RAD51, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCL and FANCM, focusing on a pathway-centric approach to identify positive selection in vertebrates [115] , about which we suggest an alternate hierarchical analysis that first considered clades of closely related eukaryotes to ensure that on an average ݀ ே ~ 1
at the codon level. Using distantly related orthologs, from humans to fish, the author concluded positive selection at specific codons in most of those fifteen genes but negative selection pressure for RAD51, FANCA and FANCG genes [115] .
The divergence of humans from early vertebrates, such as fish, may be traced back to hundreds of million years ago. Ideally, models of codon evolution have been optimized for closely related orthologs, where on the average a single nonsynonymous substitution may be hypothetically anticipated per codon. If judiciously implemented, theoretical approaches from such comparative sequence analysis help identify putative molecular adaptations in a species-specific context, which may subsequently be validated using experimental assays. Using this extensive background, we shall now proceed to appreciate how the genome-level sequence evolution, in the context of human evolution, may help trace the genetic etiology of lifestyle-related complex multifactorial diseases, such as CVD.
(End of Box 4)
2 2
Comparative genomic study can determine a unique hierarchy of common genetic variants from patients with stratified levels of disease severity
Modern genotyping platforms, such as microarrays, enable us to systematically probe the inherited genotype at unique and predetermined SNP loci (for example, the Cardio-MetaboChip from Illumina [1] ). An angiography-based study of every CVD patient enabled us to designate a SYNTAX-based score for them and helped us stratify their levels of CVD severity [64, 65] (Fig. 5A ). For this comparative genomic analysis, we studied the following cohorts of human subjects: (i) all cases and controls (S TOT ), (ii) exclusively controls (S CTRL ), (iii) exclusively CVD patients (S CVD ), (iv) most severe CVD patients (S sevCVD_1 ), (v) CVD patients with intermediate severity (S sevCVD_2 ), and (vi) CVD patients with least severity (S sevCVD_3 ) (Fig. 5A) , and probed the genotype of all individuals at SNPs genome-wide. Next, we performed an iterative computational analysis (Fig. 5B ), using the genotype from the designated cohorts (Fig. 5A ). We first computed the Shannon entropy ሺ ܵ ሻ [3] (See Box 5) at every SNP locus that was probed by our microarray. Furthermore, for quality control purposes, we omitted genotype information recorded by faulty probe(s). After ensuring ܵ ൌ 0
for that locus, we also computed the zygosity at that locus (Fig. 5B ). Independent instances of autosomal recessive [116] as well as dominant mutations [117, 118] have been traced to familial hypercholesterolemia, which in turn associates with CVD. Hence, we sought to compute both homozygous and heterozygous loci that were exclusively invariant among controls and CVD patients. 
CVD cases and corresponding gender-and age-matched controls have a shared ancestry
Although it is common knowledge that the CVD cases and controls from an outbred native subpopulation have a shared ancestry, nevertheless we illustrate this by counting the number of unique invariant genotype for all SNP loci. If individuals have diverged
Computing the Shannon entropy at the SNP locus
Modern microarray platforms, such as the Cardio-MetaboChip [1] , probe the genotypic at predetermined genomic coordinates, which are identical across all subjects -cases and controls.
Hence, the genotype data analyzed was analogous to a MSA and ready for a comparative genomic analysis. However, neighboring nucleotides were megabase apart and not adjacent nucleotides from a complete genome. The different genotype probed at a locus, per subject may be annotated in 11 ways. We considered four homozygous calls (AA, TT, GG, CC), six heterozygous calls (AT, AG, AC, TG, TC, GC) and "--" as "bad call" for incorrect / poor quality genomic information that was probed therefore,
Then, for a given study cohort, the Shannon entropy . Once invariant loci are computed, their genotype information is used to identify zygosity at that locus ( Fig. 5B ).
(End Box 5) 2 4 around the same time, from a common ancestor, then the numbers of evolutionarily conserved SNP loci per chromosome may be at par among CVD cases and controls.
Such an exercise is motivated because an early onset of CVD is reversible [23] and the human subjects that we studied were all native to India. For a gender-and age-matched case versus control study, the genome-wide identification of statistically consistent number of distinctly invariant loci, on identical chromosomes, may suggest similar evolutionary divergence time from their shared ancestry [44] . We did not do this analysis at the gene-level because most invariant loci were intergenic (unpublished results).
Hence, we sought to identify and annotate all invariant loci from the mutually exclusive studies of S CTRL and S CVD respectively. We computed ܵ for all SNP loci genome-wide, from a 3-way comparative study, using those two mutually exclusive genomic data sets:
S CTRL -S TOT and S CVD -S TOT (Fig. 6A) . Here, the subtracted part S TOT implies that all SNP loci that were computed with invariant genotype from the S TOT study were omitted from those in S CTRL and S CVD .
Here, it is our goal to show that the numbers of exclusively invariant homozygous loci (apportioned per chromosome), and exclusive to either the CVD or control cohorts are at par. Our proposed null hypothesis is that the distribution of all invariant loci from the two mutually exclusive cohorts is statistically consistent. The alternate hypothesis proposed is that the two distributions are statistically inconsistent, suggesting that the two cohorts did not diverge around the same time, from an ancestral population. Using the nonparametric Kruskal-Wallis test to compute if the likelihood of the two distributions was statistically consistent, we report that the null hypothesis is tenable (P < 0.23). In addition, we also computed the ratio of the total number of invariant loci, apportioned per chromosome, from CVD patients with respect to control subjects. We report that the ratio of numbers of invariant loci from the CVD to control cohort is at par (Fig. 6B) . On 2 5 representing the same ratio in a histogram, we report that the histogram mean ൎ 1 (Fig.   6C ), which confirms that the number of invariant loci from the cases and controls are at par. On repeating the analysis with invariant loci exclusively from the protein-coding genome, we were able to cross check those results and independently computed another histogram with mean ൎ 1
, but with an expectedly greater variance because there were fewer invariant loci (results not shown). Taken together, our results support the fact that the individual CVD cases and controls, have diverged from a common ancestral subpopulation and therefore we may attempt to trace the common evolutionary etiology of CVD by tagging loci that were invariant in a hierarchical manner -for example distinct loci were manifest invariant in the combined cohort, among the controls, and among CVD cases.
3-way comparative genomic study of invariant homozygous loci
Next, using the previously computed loci, we continued to seek additional insights and perspectives from the study of invariant homozygous loci, which were computed in three different ways: from all individuals, only CVD cases and only controls. To identify and annotate all genes with at least one invariant homozygous locus, which was distinct from the CVD versus control cohort, we did a 3-way comparative genomic analysis of S TOT , S CTRL and S CVD cohorts. Using the Venn diagram in Fig. 6A , we represented seven distinct sectors V1-V7, each representing the genes or intergenic regions that had such invariant loci from S TOT , S CTRL , and S CVD . We denote those studies as S V1 -S V7 and will only focus on the S V1 study to identify genes with the three different types of variants that manifest uniquely in these cohorts. More specifically, we sought genes that represented the sector V1 from the 3-way overlap (Fig. 6A) , which may be represented by hypothetical genes GENE_G1 and GENE_G3 (Fig. 7) . From this analysis we were able to identify LDLR along with other genes (unpublished results). As mentioned earlier, 2 6 distinct LDLR variants are implicated in lipid regulation and metabolism [49] , which manifested gain-of-function and loss-of-function, and hence our formalism warrants further scrutiny using this evolutionary-based perspective.
Exclusively conserved loci in patients with most severe CVD (S sevCVD_1 study)
To further the genetic etiology of CVD, we sought out the common variants that were not conserved in CVD cohort, and with a prototypical hierarchy that represented the paradigm exclusively from the hypothetical GENE_G3 in Fig. 7 . As mentioned before, angiography-based studies (SYNTAX-based scoring [64, 65] ) were used to stratify the severity in CVD patients. The patients grouped as most severe (S sevCVD_1 ) had multiple manifestations of severe arterial blockages (unreported results). Therefore, to characterize the genetic etiology of severe CVD cases, using the workflow described earlier (Fig. 5B) , we sought to compute those invariant homozygous and heterozygous SNP loci that were exclusive only to that cohort (S sevCVD_1 ).
This analysis is analogous to seeking invariant genotype in a MSA, where a few aligned sequences from a set of homologs will yield greater conserved positions, and as more and more homologs are added, the number of conserved positions will recede, or at best remain constant. Hence, we anticipate that the study with most severe CVD patients will result is a larger set of invariant loci than the combined study of patients with least severity, intermediate severity and highest severity. As the cohort size for severe CVD is smaller compared to the full CVD cohort, a genome-wide search for loci with exclusively invariant genotype among them is likely to yield more false positive loci than true positive ones. Therefore, we take a three-tire approach (described next) to sequentially filter out as many false positives as possible, and only compute the homozygous and heterozygous invariant loci that were exclusive to S sevCVD_1 . 2 7 An iterative and hierarchical strategy to identify unique common variants from the cohort of most severe CVD cases (S sevCVD_1 )
Using S sevCVD_1 , we compute the ܵ for all SNP loci, and delineated the homozygous and heterozygous loci with ܵ ൌ 0
. In the first tire of analysis, we omitted all invariant loci that were already identified in the S TOT study cohort. Next, in the second tire, using all remaining loci, we subsequently omitted the homozygous / heterozygous invariant loci from the CVD patient study cohort S CVD . Finally, in the final third tire, we combined cohorts of intermediate (S sevCVD_2 ) and lowest CVD severity (S sevCVD_3 ) to progressively narrow down our search for invariant SNP loci that were exclusively invariant among the most severe CVD subjects and not otherwise.
In a nutshell, on iterating the analysis outlined here, for different subject cohorts: both case and controls (S TOT ), only controls (S CTRL ), only CVD patients (S CVD ), most severe CVD patients (S sevCVD_1 ), CVD patients with intermediate severity (S sevCVD_2 ) and CVD patients with least severity (S sevCVD_3 ), and filtering out SNV loci obtained from any cohort at higher hierarchy, we will systematically gain access to the genetically invariant loci for cohorts such as S sevCVD_1 , S sevCVD_2 and S sevCVD_3 .Therefore, using a 3-way and three-tire severity-derived CVD data, a robust comparative genomics study is proposed to understand why common genetic variants persist as invariant loci only in very specific cohorts, such as the most severe CVD cohort, and why the same genes manifest markedly different and hierarchical variants.
Moreover, after classifying CVD patients by their levels of severity, a comparative genomic analysis across the severe category will surely enable us to identify the invariant loci that are unique among identical set of genes or intergenic regions 2 8 (GENE_G3 in Fig. 7 ). We report that such invariant loci are largely inter-genic, with consecutive invariant loci span genomic distances in megabase scale. However, it is beyond our scope to determine if those variants represent a gain-of-function / loss-offunction paradigm [56, 57] , or are benign [119] .
Genes computed using this 3-way comparative genomic study represent putative candidates for multifactorial CVD severity. Therefore, we hypothesize here that genes that manifest evolutionary plasticity from: (i) the 3-way analysis study of S V1 , (ii) with exclusively invariant homozygous and/or (iii) heterozygous loci in the severe CVD cohorts, may be used to trace the hierarchical etiology of this complex multifactorial disease, either directly modulating physiological function or via its interactors, so as to reverse the disease prognosis [23] . We also emphasize that our results are along the lines of the seminal discovery involving evolutionary plasticity of the LDLR gene, wherein it was shown that unique variants of the gene gave rise to both loss-of-function and gainof-function [49] . Hence, more importantly a candidate-gene based search strategy may putatively enable us to identify common genetic variants having unique evolutionary plasticity that is manifest in diseases with differential severity.
Conclusion
In this perspective, we have presented alternate perspectives and insights to trace the etiology of CVD from a very small study set (50% CVD cases and 50% controls)
representing an outbred subpopulation from India. We show that it is possible to identify genetic variants from CVD patients stratified by disease severity. The hierarchical plasticity of those variants led us to identify a constellation of genetic variants unique to CVD cases that were stratified by differential levels of disease severity. Consequently, 2 9 interactions among various proteins that originate from variant genes may give rise to a differential response. Taken together, this work opens up avenues for inter-disciplinary analyses that may complement genome wide association studies.
As a primer to computational molecular evolution, we have synopsized that genomes have evolved uniquely in among disparate species, from independently published reports. Accordingly, we highlighted instances of diverse molecular adaptations among interacting proteins across species. Novel insights and perspectives developed here are for motivating a paradigm shift and for wider education that may lead to a better understanding of disease paradigm using an evolution-based approach.
Outlook
The perspective presented is not restricted to CVD or lifestyle-related diseases and may be explored in the context of diverse diseases, for example autism where in a rational basis for stratification of disease severity exists. 
Figure 6. Comparative genomic study demonstrates similar evolutionary divergence times of CVD cases versus age-and gender-matched controls. (A) A
Venn diagram that represents the study plan for a 3-way comparative genomics approach. (B) A bar graph describes the ratio of total number of exclusively invariant loci, apportioned per chromosome, obtained from the CAD cohort with respect to the controls, is illustrated here. All loci that were identical to both cohorts were subtracted first. (C) The same ratio from (B) is now described using a histogram, which has been fitted to a Gaussian function (normal distribution). Genotypic profile across human controls and CAD patients
GENE_G1 GENE_G3 GENE_G2
Conserved genotype across all individuals studied: CAD patients and age-, gender-matched controls (** shown on top margin) Conserved genotype in all CAD cases only but not fully conserved in control cohort (* shown on top margin) Conserved genotype in from all controls only but not fully conserved in CAD cohort (* shown on bottom margin)
3' 5'
A discontinuity in genomic coordinates Schematic representation of genomic elements is not to scale, CVD patients are represented as P_1 to P_N and controls C_1 to C_N on the left margin Genotype of CVD patients
Genotype of controls
Conserved genotype across all severe CAD cases (1) 1) and (2)), but not invariant across all patients or in controls
All CVD cases are categorized as per their SYNTAX scores: an angiographic tool stratifying the complexity of CVD with highest severity (1), intermediate severity (2) , and least severity (3) -shown on right margin.
